Choose Your Horizon Raises $215,000 to Expand At-Home Ketamine Therapy

Austin, Texas-based Choose Your Horizon launched the fundraising campaign on Oct. 31.

Choose Your Horizon, a mental-wellness company offering at-home psychedelic therapy, has raised more than $200,000 through a crowdfunding campaign on StartEngine.

As of Dec. 5, the Austin-based company had raised $215,756 on the StartEngine platform, selling equity in the company at 50 cents per share.

Choose Your Horizon has developed a proprietary “telemedicine wellness platform,” using clinical-outcomes data, to connect patients with medical specialists who can prescribe at-home ketamine treatments for depression, anxiety and PTSD and to enable patients to get the most out of their therapy, according to the company.

The company said it will use the funds to continue its expansion beyond the 15 states where it currently operates. 

“We are beyond excited at the level of support we’ve received so far in the campaign,” founder and CEO Mark Holland said. “It’s been an even stronger start than we were anticipating, and we fully expect to reach our funding goal.”

With an average order value of $1,000, Choose Your Horizon has sold more than 2,200 treatment packages, according to data posted on its StartEngine page. The company has delivered more than 6,000 ketamine-assisted therapy sessions across 15 states, according to Choose Your Horizon, with 98% of clients reporting an improvement in symptoms.

In the last year, Choose Your Horizon has seen a 55% compounded quarterly growth rate, according to the company.

Choose Your Horizon describes its telemedicine platform as “an alternative for people who have tried numerous other treatment options with little to no success.”

The company adds on its StartEngine page: “By investing in Choose Your Horizon, you’re not only aligning with a transformative force in mental health but also with a company dedicated to personalized, high-caliber patient experiences that make a real difference in people’s daily lives.”

Editor’s note: This story was updated on Dec. 5, 2023.